CH415587A - Process for the preparation of N-alkyl-substituted 3-methoxy-4-carbamidomethoxyphenylacetic acid alkyl and alkenyl esters - Google Patents
Process for the preparation of N-alkyl-substituted 3-methoxy-4-carbamidomethoxyphenylacetic acid alkyl and alkenyl estersInfo
- Publication number
- CH415587A CH415587A CH319466A CH319466A CH415587A CH 415587 A CH415587 A CH 415587A CH 319466 A CH319466 A CH 319466A CH 319466 A CH319466 A CH 319466A CH 415587 A CH415587 A CH 415587A
- Authority
- CH
- Switzerland
- Prior art keywords
- alkyl
- methoxy
- substituted
- carbamidomethoxyphenylacetic
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
Description
Verfahren zur Herstellung von N-alkylsubstituierten 3-Methoxy-4-car. bamidomethoxyphenylessigsäurealkyl-und-alkenylestern
Es wurde gefunden, dass N-alkylierte 3-Methoxy4-carbamidomethoxyphenylessigsäurealkyl-und-alkenylester intravenös anwendbare, überraschend kurz wirkende Narkotika darstellen, die sich gegenüber den für diesen Zweck bisher ausschliesslich verwandten Barbitursäurederivaten im Tierversuch durch einen sehr schnellen Wirkungsabfall und durch das Fehlen des sogenannten ¸overhang¯ auszeichnen.
Erfindungsgemäss werden diese Verbindungen dadurch hergestellt, dass man entsprechende N-alkylsubstituierte 3-Methoxy-4-carbamidomethoxyphenylessigsäuren mit gesättigten oder ungesättigten aliphatischen Alkoholen verestert oder niedere N-alkylsub stituierte 3-Methoxy-4-carbamidomethoxyphenylessigsäurealkylester, wie z. B. den Methylester, durch Umestern mit höheren Alkoholen in die entsprechenden höheren Ester überführt.
Der nach dem erfindungsgemässen Verfahren erhältliche 3-Methoxy-4-N, N-diäthylcarbamidometh oxyphenylessigsäure-n-propylester wurde mit dem be- kannten 5-Methyl-5-cyclohexenyl-N-methyl-barbitur- sauren Natrium verglichen. Dabei ergaben sich beim Hund bei intravenöser Anwendung folgende Resultate :
Verfahrens-Vergleichs produkt produkt a) Dosis 40 mg/kg 40 mg/kg : g b) NarkoseGtadium 8 VI VI c) gesamt-Narkosezeit 17 Min. 166 Min.
d) Narkosezeit von
VI-IV in % der Ge- samt-Narkosezeit * 47% 17%
Beim Kaninchen liegen gleichsinnige Ergebnisse
Es zeigte sich demnach, dass bei gleicher Dosierung das nach dem erfindungsgemässen Verfahren gewonnene Produkt dieselbe Narkosetiefe zu erreichen erlaubt wie das Vergleichsprodukt, jedoch bei ganz wesentlich kürzerer Gesamt-Narkosedauer.
(Hierbei wird unter Gesamt-Narkosedauer die Zeit vom Eintritt der Narkose bis zum Verschwinden jeglicher narkotischer Symptome verstanden, also bis zu dem Zeitpunkt, zu dem das Tier sich wieder volSkommen normal verhält. Auf den Menschen übertragen, gibt dieser Zeitpunkt einen Anhalt für die Strassenfähigkeit des narkotisierten Individuums).
Demzufolge führt das erfindungsgemäss erhält- liche Produkt zu einer ganz wesentlich rascheren Strassenfähigkeit als das Vergleichsprodukt, ein Vor- teil, der sich besonders in der kleinen Chirurgie, bei der nur sehr kurze Narkosezeiten erforderlich sind, von ausschlaggebender Bedeutung ist. Abgesehen von dem Vergleichsprodukt sind auch bei den übrigen eingeführten, intravenös anzuwendenden Narkotika solche kurzen Narkosezeiten-bei Erreichung des voNen Toleranzstadiums-nicht bekannt geworden.
Beispiel 1
50 g des 3-Methoxy-4-N, N-diäthylcarbamidomethoxy- phenylessigsäuremethylesters werden in 300 ml n-Propanol gelöst und nach Zugabe von 0, 1 g Natrium-n-propylat an einer wirk * Narkose-Stadium VI entspricht nach Magnus-Girndt tiefer Narkose mit völliger Reflexlosigkeit ; Narkose-Stadium IV entspricht Seitenlage bei erhaltenem Corneal-und Kneif
Reflex. Die Zeit von Narkose-Stadium VI bis IV ist etwa ein Massstab für die für operative Eingriffe zur Verfügung stehende Zeitspanne. samen Kolonne so lange erhitzt, bis kein Methanol mehr übergeht. Nach Verjagen des überschüssigen Propylalkohols destilliert man im Vakuum und erhält 46 g des
3-Methoxy-4-N, N-diäthylcarbamido- methoxyphenylessigsäure-n-propylesters von Kp. 0,7 210-212¯.
Beispiel 2
20 g 3-Methoxy-4-N, N-carbamidomethoxy- phenylessigsäure (Schmp. 119-120 ), die aus dem Methylester durch Verseifung mit Alkali erhaltlich ist, wird mit 200 ml 3 % Chlorwasserstoff enthalitendem m-Propylalkohol 8 Stunden am Rückflusskühler erhitzt. Nach Verjagen des Lösungsmittels Tiimmt man in Benzol auf, wäscht mit Natriurncarbonafl¯sung und Wasser und trocknet mit Natriumsulfat. Nach Verjagen des Benzols de stilliert man den Rückstand im Vakuum und erhält 19, 8 g
3-Methoxy-4-N, N-diäthylcarbamido- methoxyphenylessigsäure-n-propylester vom Kp.0.7 210-212¯.
Beispiel 3
50 g 3-Methoxy-4-N,N-diÏ'thylcarbanudo methoxyphenylessigsäuremlethylester werden in 300 ml Allylalkohol gelöst und nach Zugabe von 0, 1 g Natrium am Intensivkühler erhitzt, bis kein Methano mehr übergeht. Nachdem der überschüssige Allylalkohol entfernt ist, wird das Produkt unter Vakuum destilliert, und man erhält 43 g
3-Methoxy-4-N, N-diäthylcarbamido- methoxy-phenylessigsäureallylester vom Kp. o, 8 208-210 .
Process for the preparation of N-alkyl-substituted 3-methoxy-4-car. alkyl and alkenyl esters of bamidomethoxyphenylacetic acid
It has been found that N-alkylated 3-methoxy4-carbamidomethoxyphenyl acetic acid alkyl and alkenyl esters are surprisingly short-acting narcotics which can be used intravenously and which, compared with the barbituric acid derivatives, which have hitherto been exclusively used for this purpose, differ in animal experiments due to a very rapid decrease in activity and the absence of the so-called Mark ¸overhang¯.
According to the invention, these compounds are prepared by esterifying corresponding N-alkyl-substituted 3-methoxy-4-carbamidomethoxyphenylacetic acids with saturated or unsaturated aliphatic alcohols or lower N-alkyl-substituted 3-methoxy-4-carbamidomethoxyphenylacetic acid alkyl esters, such as. B. the methyl ester, converted into the corresponding higher esters by transesterification with higher alcohols.
The 3-methoxy-4-N, N-diethylcarbamidomethoxyphenylacetic acid-n-propyl ester obtainable by the process according to the invention was compared with the known 5-methyl-5-cyclohexenyl-N-methyl-barbituric acid sodium. The following results were obtained in the dog when administered intravenously:
Process comparison product product a) dose 40 mg / kg 40 mg / kg: g b) anesthesia grade 8 VI VI c) total anesthetic time 17 min. 166 min.
d) anesthetic time from
VI-IV in% of the total anesthetic time * 47% 17%
The results for rabbits are the same
It was accordingly found that with the same dosage, the product obtained by the method according to the invention allows the same depth of anesthesia to be achieved as the comparison product, but with a significantly shorter total anesthetic duration.
(The total duration of anesthesia is understood to mean the time from the onset of anesthesia to the disappearance of any narcotic symptoms, i.e. up to the point in time at which the animal behaves completely normally again. Transferred to humans, this point in time provides an indication of roadworthiness of the anesthetized individual).
As a result, the product obtainable according to the invention leads to a considerably faster roadworthiness than the comparative product, an advantage which is of decisive importance especially in minor surgery, where only very short anesthetic times are required. Apart from the comparative product, no such short anesthetic times - when the full tolerance stage has been reached - have become known for the other introduced narcotics to be used intravenously.
example 1
50 g of 3-methoxy-4-N, N-diethylcarbamidomethoxyphenyl acetic acid methyl ester are dissolved in 300 ml of n-propanol and, after the addition of 0.1 g of sodium n-propoxide, an anesthetic stage VI corresponds to Magnus-Girndt deep anesthesia with complete lack of reflexes; Stage IV anesthesia corresponds to the lateral position with the corneal and pincer intact
Reflex. The time from anesthesia stage VI to IV is roughly a measure of the time available for surgical interventions. seed column heated until no more methanol passes over. After driving off the excess propyl alcohol, the mixture is distilled in vacuo and 46 g of des is obtained
3-Methoxy-4-N, N-diethylcarbamidomethoxyphenylacetic acid n-propyl ester of bp 0.7 210-212¯.
Example 2
20 g of 3-methoxy-4-N, N-carbamidomethoxyphenylacetic acid (melting point 119-120), which can be obtained from the methyl ester by saponification with alkali, is refluxed with 200 ml of m-propyl alcohol containing 3% hydrogen chloride for 8 hours . After the solvent has been driven off, it is taken up in benzene, washed with sodium carbonate solution and water and dried with sodium sulfate. After driving off the benzene, the residue is distilled in vacuo and 19.8 g are obtained
3-Methoxy-4-N, N-diethylcarbamido methoxyphenyl acetic acid n-propyl ester of boiling point 0.7 210-212¯.
Example 3
50 g of 3-methoxy-4-N, N-diÏ'thylcarbanudo methoxyphenylessigsäuremlethylester are dissolved in 300 ml of allyl alcohol and, after the addition of 0.1 g of sodium, heated in an intensive cooler until no more methano passes over. After the excess allyl alcohol has been removed, the product is distilled under vacuum and 43 g are obtained
3-Methoxy-4-N, N-diethylcarbamido-methoxy-phenylacetic acid allyl ester of bp. O.8208-210.
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEF31176A DE1134981B (en) | 1960-05-06 | 1960-05-06 | Process for the preparation of N-substituted 3-methoxy-4-carbamidomethoxyphenyl acetic acid alkyl and alkenyl esters |
Publications (1)
Publication Number | Publication Date |
---|---|
CH415587A true CH415587A (en) | 1966-06-30 |
Family
ID=7094083
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH444361A CH425762A (en) | 1960-05-06 | 1961-04-14 | Process for the preparation of N-alkyl-substituted 3-methoxy-4-carbamidomethoxyphenylacetic acid alkyl and alkenyl esters |
CH319466A CH415587A (en) | 1960-05-06 | 1961-04-14 | Process for the preparation of N-alkyl-substituted 3-methoxy-4-carbamidomethoxyphenylacetic acid alkyl and alkenyl esters |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH444361A CH425762A (en) | 1960-05-06 | 1961-04-14 | Process for the preparation of N-alkyl-substituted 3-methoxy-4-carbamidomethoxyphenylacetic acid alkyl and alkenyl esters |
Country Status (5)
Country | Link |
---|---|
BE (1) | BE603477A (en) |
CH (2) | CH425762A (en) |
DE (1) | DE1134981B (en) |
DK (1) | DK104841C (en) |
GB (1) | GB906250A (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1300545B (en) * | 1965-02-24 | 1969-08-07 | Bayer Ag | Process for the preparation of 2- (N, N-dialkyl- or N-alkyl-N-alkoxy-carbamoyl-methoxy) -benzoic acid esters substituted in the 5-position |
IT1204778B (en) | 1986-02-04 | 1989-03-10 | Mazzarella Basilio | INJECTABLE PHARMACEUTICAL FORMULATIONS OF ACTIVE INGREDIENTS FOR GENERAL ANESTHETIC ACTIVITIES |
PL207038B1 (en) | 2002-01-25 | 2010-10-29 | Theravance | Short-acting sedative hypnotic agents for anesthesia and sedation |
JP4153949B2 (en) * | 2002-05-09 | 2008-09-24 | セラヴァンス, インコーポレーテッド | Short-acting sedative hypnotics for anesthesia and sedation |
DK1648413T3 (en) | 2003-07-23 | 2010-01-11 | Theravance Inc | Pharmaceutical preparations of short-acting sedative sleep-spraying agent |
-
1960
- 1960-05-06 DE DEF31176A patent/DE1134981B/en active Pending
-
1961
- 1961-04-14 CH CH444361A patent/CH425762A/en unknown
- 1961-04-14 CH CH319466A patent/CH415587A/en unknown
- 1961-05-04 GB GB1628061A patent/GB906250A/en not_active Expired
- 1961-05-05 BE BE603477A patent/BE603477A/en unknown
- 1961-05-05 DK DK186961A patent/DK104841C/en active
Also Published As
Publication number | Publication date |
---|---|
DK104841C (en) | 1966-07-11 |
CH425762A (en) | 1966-12-15 |
GB906250A (en) | 1962-09-19 |
DE1134981B (en) | 1962-08-23 |
BE603477A (en) | 1961-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2635853A1 (en) | PYRROLIDINE-2-ON DERIVATIVES, THE PROCESS FOR THEIR MANUFACTURING AND THE MEDICINAL PRODUCT CONTAINING THEY | |
DE2036421C (en) | ||
CH415587A (en) | Process for the preparation of N-alkyl-substituted 3-methoxy-4-carbamidomethoxyphenylacetic acid alkyl and alkenyl esters | |
EP0133935B1 (en) | P-oxybenzoic acid derivatives, methods for preparing them, and their use for the preparation of medicaments with hypolipemic activity | |
CH638510A5 (en) | PROSTACYCLINANALOGA. | |
DE2350148A1 (en) | THIOPHENE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | |
CH628632A5 (en) | METHOD FOR THE PRODUCTION OF FIELD ACID ESTERS OF PHENOTHIAZINE DERIVATIVES. | |
DE2817494A1 (en) | AMINO ALCOHOL DERIVATIVE | |
CH621786A5 (en) | Process for the preparation of a novel behenic acid ester | |
DE2503135C3 (en) | Terpene compounds, processes for their preparation and pharmaceuticals containing these products | |
DE3013502C2 (en) | [2 "- (Trifluoromethyl) -phenthiazin-10" -yl- (n-prop-3 "" ylpiperazin-4 "" - yleth-2 "" "- yl)] ester, method for the production of the same and medicinal products containing them | |
EP0019069A2 (en) | 6-Keto PGE1 compounds, their preparation and therapeutic application, PGI1 compounds | |
DE2438884A1 (en) | NEW DERIVATIVES OF 5-HYDROXYMETHYLTHIAZOLE, THE PROCESS FOR THEIR MANUFACTURING AND PHARMACEUTICAL COMPOSITIONS | |
DE2211214A1 (en) | Thiophendenvates and processes for their preparation | |
CH441272A (en) | Process for the preparation of substituted 3,4-dihydroxybenzoic acid esters | |
AT224631B (en) | Process for the preparation of new N-alkyl-substituted 3-methoxy-4-carbamidomethoxyphenylacetic acid alkyl and alkenyl esters | |
DE1018070B (en) | Process for the preparation of anesthetically active N-alkylaminocarboxylic acid anilides | |
DE2141357C3 (en) | Bis (4-chlorophenoxy) acetic acid esters, process for their preparation, medicaments containing these compounds | |
DE2616657A1 (en) | OXADIAZOLE DERIVATIVES AND THEIR SALTS, PROCESS FOR THEIR MANUFACTURING AND PHARMACEUTICAL COMPOSITIONS | |
DE603088C (en) | Process for the preparation of a physiologically highly effective conversion product from vitamin D irradiated with ultraviolet rays | |
AT160397B (en) | Process for the preparation of l-ascorbic acid. | |
DE2404924A1 (en) | ERGOLINE DERIVATIVES | |
DE1097986B (en) | Process for the production of 6ª ‡ -Methyl-17ª ‡ -oxyprogesterone and its esters | |
DE1543842C3 (en) | 3-Oxo-2-oxa-4,9, l 1-gonatriene, process for their preparation and pharmaceuticals containing them | |
CH205522A (en) | Process for the preparation of a 20-ketone of the cyclopentanopolyhydrophenanthrene series. |